Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 Months' experience

Rita M. Braziel, Teresa M. Launder, Brian J. Druker, Susan B. Olson, R. Ellen Magenis, Michael J. Mauro, Charles L. Sawyers, Ronald L. Paquette, Michael E. O'Dwyer

Research output: Contribution to journal › Article › peer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 Months' experience'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds